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Abstract Numerous biomaterials are being considered for
cartilage tissue engineering, while scaffold-free systems
have also been introduced. Thus, it is important to know do
the scaffolds improve the formation of manufactured neo-
cartilages. This study compares scaffold-free cultures to two
scaffold-containing ones. Six million bovine primary
chondrocytes were embedded in HyStem™ or Hydro-
Matrix™ scaffolds, or suspended in scaffold-free chon-
drocyte culture medium, and then loaded into agarose gel
supported culture well pockets. Neocartilages were grown
in the presence of hypertonic high glucose DMEM medium
for up to 6 weeks. By the end of culture periods, the formed
tissues were analyzed by histological staining for pro-
teoglycans (PGs) and type II collagen, gene expression
measurements of aggrecan, Sox9, procollagen α1(II), and
procollagen α2(I) were performed using quantitative RT-
PCR, and analyses of PG contents and structure were
conducted by spectrophotometric and agarose gel electro-
phoretic methods. Histological stainings showed that the
PGs and type II collagen were abundantly present in both
the scaffold-free and the scaffold-containing tissues. The
PG content gradually increased following the culture per-
iod. However, the mRNA expression levels of the cartilage-
speciﬁc genes of aggrecan, procollagen α1(II) and Sox9
gradually decreased following culture period, while
procollagen α2(I) levels increased. After 6-week-cultiva-
tions, the PG concentrations in neocartilage tissues manu-
factured with HyStem™ or HydroMatrix™ scaffolds, and
in scaffold-free agarose gel-supported cell cultures, were
similar to native cartilage. No obvious beneﬁts could be




Today, tissue engineering is considered to offer great pos-
sibilities for the ﬁeld of regenerative medicine, and
researchers working on various disciplines of the regen-
erative medicine show great interest on it worldwide. The
principle of the tissue engineering is to regenerate neo-
tissues by using cells, biomaterials and/or signaling
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molecules to replace the lost or damaged tissue. Although
there has been some limited success, lately some promising
new results have been introduced [1, 2].
Articular cartilage is basically quite simple tissue in its
structure and function. Therefore, it seems to be one of the
most ideal candidates for the tissue engineering approaches
[3]. Yet, there are no standardized methods available at
present to reproducibly succeed in the regeneration of a
perfect functional articular cartilage in vitro. Obviously, the
problem lies in the ability to create a correct ﬁne structure of
the tissue extracellular matrix. It is relatively easy to grow a
cartilage-like tissue in laboratory conditions, but usually the
tissues lacks a zonal organization and resilience of the true
articular cartilage [4, 5].
The development of better culture methods is often
achieved by testing new protocols step by step. By system-
atically going through the different options, a true knowledge
of the steps of importance can be gathered. Earlier, we have
optimized our neocartilage culture conditions using a
scaffold-free culture system. Contrary to our hypothesis, we
noticed that low oxygen tension and glucosamine sulphate
supplementation were not beneﬁcial for the neocartilage for-
mation in a three-dimensional scaffold-free culture system [6],
although 5% oxygen in monolayer cultures was advantageous
for gene expressions of aggrecan and procollagen α1(II) [7].
On the other hand, a hypertonic (390mOsm) high glucose
(4.5 g/l) culture medium under normal oxygen tension (20%
O2) enhanced the neocartilage formation in the scaffold-free
primary chondrocyte culture system [8]. Analyses based on
histological stainings, relative cartilage-speciﬁc gene expres-
sions and proteoglycan (PG) contents showed that these
culture conditions were better than the regular culture con-
ditions [8]. Notably, a transient transforming growth factor-β3
(TGF-β3) supplementation revealed no beneﬁt at all when
compared to the non-supplemented cultures under the same
conditions [8], even though it has been shown previously that
the transient supplementation of TGF-β1 or TGF-β3 stimu-
lated the extracellular matrix synthesis of the tissue-
engineered cartilage [9].
In our previous studies, irregular shapes of the neo-
cartilages were often formed, and especially the surface
proﬁles could be variable. In this study, our goal was to
optimize our culture method by embedding the chon-
drocytes into commercial scaffold materials HyStem™ and
HydroMatrix™. The scaffold materials were expected to aid
in the tissue formation, giving the neocartilages support
especially at the beginning of the cultivation and, therefore,
speed up the process of tissue assembly. The agarose well
culture system, similar to those introduced previously
[10–12], were considered to provide the neocartilages with
better conditions for nutrients and O2 supplies and, there-
fore, prevent the possible necrotic events in the neotissues
due to suboptimal culture conditions.
The HyStem™, a synthetic hyaluronan product, is a
native material for articular cartilage modiﬁed with func-
tional thiol-groups. This allows the scaffold material to be
crosslinked using certain crosslinking agent. Hydro-
Matrix™ is a synthetic self-assembling peptide, which can
be used to form hydrogels by changes in temperature or in
ionic strength. The feasibility of these materials for cartilage
tissue engineering was tested in this study in comparison to
scaffold-free cultivations.
2 Materials and methods
2.1 Preparation of agarose gel wells
First, 1% agarose gel was prepared in phosphate-buffered
saline (PBS) and heated in microwave oven. The soluble gel
was poured into a 6-cm cell culture plate after a speciﬁc
cylinder-shaped mold (diameter= 10 mm) was put on the
plate to form the wells in the gel. After gelation at room
temperature for about 1 h, the mold was taken away, and the
gel well plates were ready for cell culture (Fig. 1).
2.2 Isolation of chondrocytes and cell seeding
Cartilage was harvested from bovine femoral condyles
provided by HK Scan (Outokumpu, Finland) and Ström-
dahla (Nordmaling, Sweden) abattoirs. The chondrocytes
were isolated by overnight collagenase digestion in high
glucose DMEM supplemented with fetal bovine serum,
penicillin, streptomycin, L-glutamine and L-ascorbic acid 2-
phosphate trisodium salt, as previously described [8].
Fig. 1 Photograph of agarose gel-support well used in the cultures
(scale bar= 1 cm)
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The next day, six million chondrocytes were seeded into
the agarose gel wells in HyStem™ or HydroMatrix™
scaffolds, or as a control without the scaffold. Chondrocytes
seeded in the HyStem™ scaffolds were prepared by mixing
six million chondrocytes into 100 µl of the HyStem™
solution and adding 25 µl of the crosslinking solution of the
kit to start the gelation process. The suspension was
immediately gently pipetted into the gel well, and placed
into a humidiﬁed incubator for 20 min. After the gelation, 5
ml of high glucose hypertonic (390 mOsm) DMEM sup-
plemented with 10% fetal bovine serum, 100 U/ml peni-
cillin, 100 µg/ml streptomycin, 2 mM L-glutamine and
50 µg/ml L-ascorbic acid 2-phosphate trisodium salt was
added into plate.
The HydroMatrix™ solution was kept on ice before
initiating the gelation, then six million chondrocytes were
mixed into the product (100 µl, ﬁnal concentration 0.25%)
and 5 ml of the hypertonic high glucose medium, supple-
mented as described above, was gently poured into the
plate. The sample was then placed into the humidiﬁed
incubator to start the gelation process and cultivation.
The scaffold-free controls, prepared by suspending six
million chondrocytes in 100 µl of the above-described high
glucose hypertonic DMEM into the agarose wells, were
placed into incubator for 1 h, and then 5 ml of the high
glucose hypertonic DMEM was very carefully added to the
plate. The samples were grown for 1, 3 and 6 weeks. After
each time point, the samples were collected for histological
staining, PG analyses and gene expression analyses. Each
tissue was also photographed for macroscopical evaluation.
The experiments were repeated for four times performing
four different chondrocyte isolations from four different
animals. For gene expression sample collection, the
experiments were repeated for six times.
2.3 Histological assays
At the end of each culture period, one sample from each
treatment and control was cut into two halves: one for the
PG analyses, while the other half was ﬁxed in 4% paraf-
ormaldehyde and processed for the histological analyses.
The samples reserved for the PG analyses were weighed in
a pre-weighed tubes to obtain the wet weight of the sample,
and then frozen in −70 °C for the further analyses.
The histological sections of the samples were stained with
Toluidine Blue, and type II collagen was immunostained
with anti-type II collagen mouse monoclonal antibody E8 [6,
13]. Envision+ System-HRP kit (Dako, Glostrup, Denmark)
was used for detection. The stained sections were then
imaged using a light microscope (Carl Zeiss Axioimager
M2, Thornwood, NY, USA). The thicknesses of the neo-
tissues were measured from the same sections using the
same device using a standard scale bar for calibration.
2.4 Analysis of the proteoglycans
The PGs were extracted with 4M guanidinium hydro-
chloride as described in our previous studies [6, 8]. The
extracted PGs were precipitated in 70% ethanol, dissolved
in water, and glycosaminoglycan (GAG) contents were
quantitated using 1,9-dimethylmethylene blue (Sigma-
Aldrich) assay [14]. Chondroitin sulfate from shark (Sigma)
was used as a standard. Separation of the extracted PGs in a
1.2% agarose gel and staining with Toluidine Blue was
performed as previously described [6].
2.5 Gene expression analyses
The gene expression analyses were performed as described
in our previous study [8]. Brieﬂy, TRI reagent (Molecular
Research Center, Cincinnati, OH, USA) was used to extract
the total RNA from each sample, and reverse transcription
was performed according to the kit’s instructions (Verso
cDNA Synthesis Kit, Thermo Scientiﬁc, Waltham, MA,
USA). The quantitative RT-PCR was accomplished by
using MX3000P Real Time PCR System (Stratagene, La
Jolla, CA, USA) as previously described [8] using the pri-
mers optimized for aggrecan [15], procollagen α2(I) [16],
procollagen α1(II) [16] and Sox9 [17]. Ribosomal protein
large P0 (RPLP0) was used as a house-keeping gene [18].
2.6 Statistical analysis
One-way analysis of variance with the Bonferroni correc-
tion was used to analyze the statistically signiﬁcant differ-
ences in the determined parameters between the different
time points, and scaffold vs. scaffold-free cultures. A dif-
ference was interpreted to be statistically signiﬁcant when
the P-value was less than 0.05.
3 Results
3.1 Macroscopical appearance and the thickness of the
neocartilages
Overall, the control and the HyStem™ samples were disc-
shaped and smoothest on the surface, whereas the tissues
grown in the HydroMatrix™ scaffolds were more often
irregularly shaped, and their surfaces were not as smooth as
in the control ones. Furthermore, the tissues grown in the
control cultures appeared slightly larger in size than
the ones grown with the scaffold materials (Fig. 2a). The
thicknesses of the neocartilages were comparable to the
native cartilage from femoral condyle (Fig. 2b). The tissues
did not increase much in height during the cell culture
period (Fig. 2b). After 6 weeks of cell culture, all the
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samples felt to be more resilient when cutting them for
further analyses, compared to the earlier time-points. The
pinkish color of the neotissues in the Fig. 2a is caused by
phenol red used in the cell culture medium.
3.2 Histological analysis
The histological stainings were used to study the tissue
structure of the neocartilages. Toluidine Blue staining
showed no obvious differences in the intensity of the
stainings between the neocartilages generated in the scaf-
folds and in the scaffold-free cell cultures at any of the three
time points (Fig. 3a). The intensities of the PG staining were
rather intense already after 1 week-cultivation, while it
slightly increased following the cell culture period in all of
the groups (Fig. 3a). The staining distributed quite evenly
and intensively throughout the histological sections in all
neocartilage tissues, although occasionally some empty,
unstained areas could be observed (Fig. 3a). The staining
intensities of the constructs were comparable to the native
cartilage (Fig. 3a).
The type II collagen immunostainings showed that there
were no clear differences in the staining intensities of the
between the neocartilages generated in the scaffold-
supported and the scaffold-free cultures, although the
staining of the neocartilages generated in the Hydro-
Matrix™ at 6 week time point appeared slightly stronger
(Fig. 3b). The intensities of the type II collagen stainings
were also similar to the native cartilage (Fig. 3b).
3.3 Proteoglycan contents and subpopulations
The contents of the GAGs increased in all neocartilages
following the cell culture time. However, there were no
statistically signiﬁcant differences in the GAG contents of
the neocartilages generated in the scaffold-supported or
scaffold-free cell cultures at any time point except between
the native and the samples cultured for 1 week [p-values:
ctrl 0.037, HyStem™ 0.050 and HydroMatrix™ 0.031
(Fig. 4a)]. The GAG contents of the tissues after 6-week-
cultivations were comparable to the content of native car-
tilage (Fig. 4a).
The agarose gel electrophoresis was used to analyze the
size distribution of the PG subpopulations. In the Toluidine
Blue-stained agarose gels, only slowly migrating bands,
consisting of the large PGs corresponding to aggrecan, were
observed in all samples (Fig. 4b). No consistent differences
in the electrophoretic mobilities could be noticed, and no
Fig. 3 Microscopical appearance of the neocartilage tissues formed in
the HyStem™ or the HydroMatrix™ scaffolds, or the scaffold-free
(Control) cultures after 1, 3 or 6 weeks of culture. The proteoglycans a
were stained with Toluidine Blue and type II collagens b were stained
with an anti-type II collagen antibody (scale bar= 200 µm). Native
native bovine articular cartilage Neg. negative control
Fig. 2 Macroscopical appearance of the neocartilage tissues generated
in the HyStem™ or the HydroMatrix™ scaffolds, or the scaffold-free
(control) cultures after 6-week culture period (scale bar= 5 mm) a The
thicknesses (mean ± 95% conﬁdence intervals, n= 4) of the neo-
cartilage tissues generated in the HyStem™ or the HydroMatrix™
scaffolds or the scaffold-free (Ctrl) cultures after 1, 3 or 6 weeks of
culture b Native: thickness of native bovine articular cartilage tissue
(mean± 95% conﬁdence intervals, n= 3)
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faster mobility bands, representing smaller PGs, were visi-
ble in any sample (Fig. 4b).
3.4 Expressions of cartilage-speciﬁc genes and
procollagen α2(I)
The quantitative RT-PCR was used to investigate the
cartilage-speciﬁc genes aggrecan, procollagen α1(II), and
Sox9, and also procollagen α2(I), mRNA expression levels
in all samples (Fig. 5). There were no statistically signiﬁcant
differences in the cartilage-speciﬁc gene expressions upon
the duration of the culture period (Fig. 5a–c), although the
levels tended to be slightly higher at the beginning of the
culture. Also, no differences were found between the dif-
ferent groups (Fig. 5a–c). However, the present study shows
that the mRNA expression level of procollagen α2(I)
remarkably increased after 1-week culture (Fig. 5d),
showing the highest expression levels in constructs cultured
for 3-weeks (Fig. 5d). There were statistically signiﬁcant
differences between the 3 week HyStem™ and the 1 week
samples (p-values: control 0.021, HyStem™ 0.021 and
HydroMatrix™ 0.033).
4 Discussion
Scaffold-free tissue engineering utilizes culture methods,
which do not use exogenous materials to support the
manufacture of three-dimensional neotissues. Thus, this
culture method can closely mimic the embryonic develop-
ment, where a high cell density in the developing anlagen
precedes matrix production [19], and to overcome certain
limitations associated with the use of scaffolds [11, 20]. For
instance, there are examples that neocartilages generated in
the scaffold-free cell cultures can produce a better cartilage
extracellular matrix, even closely similar to the native
articular cartilage [12, 21–26]. However, the scaffold
materials can be expected to shorten the time required for
the formation of cartilage tissue with appropriate biological
properties.
The present study was aimed to test whether the scaffolds
made of the HyStem™ or the HydroMatrix™ would be
beneﬁcial over the scaffold-free cultures for the neocartilage
formation in the agarose gel well-supported bovine primary
chondrocyte cultures. Agarose wells were used in this
study, since the plastic insert chondrocyte culture system we
used in previous studies [6, 8] had certain limitations in
generating an optimal cartilage-like tissue.
The HyStem™ biomaterial is a thiol-modiﬁed hyalur-
onan, which is the simplest GAG and an important com-
ponent for extracellular matrix assembly of the cartilage
[27]. Hyaluronan scaffolds have been used in cartilage tis-
sue engineering to enhance the attachment, proliferation and
differentiation of the chondrocytes [28, 29], and the
assembly of the cartilage extracellular matrix [30]. There-
fore, we hypothesized that the HyStem™ scaffold would be
beneﬁcial for the neocartilage formation in the agarose gel
support chondrocyte culture system. The Hydromatrix™
was used in the present study since it has been shown to
provide good three-dimensional matrix for the chondrocyte
proliferation [31].
However, our ﬁnding was that neither of the scaffold
materials was really superior to the scaffold-free culture.
The contents of the PGs increased in all the neocartilage
tissues generated either in the scaffold-supported or the
scaffold-free cultures over time. The mRNA expression
level of all the cartilage-speciﬁc genes [aggrecan,
procollagen α1(II) and Sox9] gradually dropped during the
Fig. 4 The relative glycosaminoglycan (GAG) contents (mean± 95%
conﬁdence intervals, n= 4) and the PG structures in the neocartilage
tissues generated in the HyStem™ or the HydroMatrix™ scaffolds, or
the scaffold-free (Control) after 1, 3 or 6 weeks of culture. Dime-
thylmethylene blue assay was used to quantify the GAG contents and
the results were normalized to the wet weight of the tissue. The
quantities were related to native bovine articular cartilage’s GAG
content a A representative ﬁgure of agarose gel used for electro-
phoretic separation of the PGs. The Toluidine Blue-stained agarose gel
revealed the PG subpopulations of the neocartilages generated in the
HyStem™ (HS) or the HydroMatrix™ (HM) scaffolds, or the
scaffold-free (CTRL) cultures after 1, 3 or 6 weeks of culture b CS
chondroitin sulfate, Native native bovine articular cartilage. Statisti-
cally signiﬁcant differences (P< 0.05) are marked with asterisks
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6-week culture period similarly in all the experimental
groups. The HyStem™ or the HydroMatrix™ scaffolds did
not show any beneﬁt on the extracellular matrix production
of the neocartilages. On the other hand, the increased
mRNA expression of procollagen α2(I) occurred after 1-
week cell culture.
The histological sections showed that the intensity of PG
staining increased along the cell culture period, even though
the cartilage speciﬁc-genes mRNA expression decreased.
This apparently means that the expression of the hyaline
cartilage-speciﬁc genes declines when the cartilaginous
tissues have accumulated an adequate amount of extra-
cellular matrix. The relatively high expression of procolla-
gen α2(I) could raise a risk that the generated tissue would
be ﬁbrocartilage in nature. However, the histological sec-
tions did not show typical ﬁbrocartilage patterns.
Many different approaches have been used for the
scaffold-free cartilage tissue engineering, such as cell sheet
engineering [20, 32], aggregate tissue engineering [21, 33],
self-assembling process [12], and insert culture [6, 8, 23].
Of these approaches, the self-organization and the self-
assembly have been the two most used categories [12].
Sufﬁcient nutritional agents, such as glucose and growth
factors, are also critical for the optimal neocartilage gen-
eration in the cell culture systems. Our previous study using
the insert cell culture system showed that the PG staining
was weaker in the middle part of the neocartilage tissue than
that at the surface or in the deep zone close to the insert
ﬁlter, which allows free diffusion of nutrients [6].
We assumed that we can improve the efﬁciency of
nutrition transfer using the agarose gel-supported well
system. Agarose system is also easy to handle, has a low
cost and a minimal biological effect on the cells and
regenerative tissues [34, 35]. The other advantage of using
the agarose gels for the cell culture is that the nutrition or
oxygen can freely diffuse through the agarose matrix. As
shown by our present results, ﬁne cartilage tissues closely
comparable to native articular cartilage could be generated
in the scaffold-free agarose gel-supported chondrocyte
cultures. However, acellular areas could also be observed.
Fig. 5 The mRNA expression levels (mean ± 95% conﬁdence inter-
vals, n= 7) of Sox9 a aggrecan b procollagen α1(II) c and procollagen
α2(I) d in the neocartilages generated in the scaffold-free cultures
(Control), or the HyStem™ or the HydroMatrix™ scaffold cultures
after 1, 3 or 6 weeks of culture. The gene expressions were normalized
to human Ribosomal Protein Large P0. Statistically signiﬁcant dif-
ferences (P< 0.05) are marked with asterisks
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Further, the agarose support could stably hold the assembly
of the tissue-engineered constructs. Previously, it has been
reported that 3-dimensional tissue-engineered cartilage
generated in agarose mold has been used for clinical
application [35].
We conclude that the scaffold-free agarose gel-support
chondrocyte culture system generated a cartilage-like tissue,
which is comparable to native cartilage. The agarose gel
wells proved to be beneﬁcial for the neocartilage formation.
The tissues self-assembled in the gel wells were regularly
shaped, and had smooth surface with hyaline cartilage–like
appearance. However, no obvious beneﬁts could be visible
in the extracellular matrix production of the generated car-
tilage tissues in the HyStem™ or the HydroMatrix™
scaffold cultures. Since the decreased cartilage speciﬁc-
genes and increased procollagen α2(I) mRNA expression
levels seen in the generated neocartilage after 1-week cell
culture, further investigations on testing some exogenous
factors supplemented in the cell culture medium during the
later culture time point are needed.
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